Beer, Martin

Nielsen, Jens

Rasmussen, Thomas Bruun

Reimann, Ilona

Uttenthal, Åse

Online Research Database In Technology

                       General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.  • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal   If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.     Downloaded from orbit.dtu.dk on: Dec 18, 2017Characterization of an E2-Substituted Cstrain Vaccine Candidate with Potential DivaVaccine PropertiesRasmussen, Thomas Bruun; Reimann, Ilona; Uttenthal, Åse; Nielsen, Jens; Beer, MartinPublication date:2011Document VersionPublisher's PDF, also known as Version of recordLink back to DTU OrbitCitation (APA):Rasmussen, T. B., Reimann, I., Uttenthal, Å., Nielsen, J., & Beer, M. (2011). Characterization of an E2-Substituted Cstrain Vaccine Candidate with Potential Diva Vaccine Properties. Poster session presented at 5thAnnual Meeting EPIZONE, Arnhem, Netherlands.IS 3: CHARACTERIZATION OF AN E2-SUBSTITUTED C-STRAIN VACCINE CANDIDATE WITH POTENTIAL DIVA VACCINE PROPERTIES RASMUSSEN, THOMAS BRUUN1; REIMANN, ILONA2; UTTENTHAL, ÅSE1; NIELSEN, JENS1; BEER, MARTIN2 VET-DTU1; FLI2 Key words: DIVA vaccine pestivirus CSFV An advantage of the use of chimeric pestiviruses as modified live vaccines against classical swine fever (CSF) resides in their capacity to be manipulated to achieve the characteristics desired for safe and efficacious DIVA vaccines. We have recently described a new chimeric virus, Riems26_E2gif engineered specifically for this purpose (Rasmussen et al. 2010). The E2 substituted Riems26_E2gif was derived by homologues recombination of the full-length E2 protein encoding genome region from Border disease strain Gifhorn into a bacterial artificial chromosome (BAC) harbouring the complete genome of the CSFV vaccine strain C-Riems. This new chimeric pestivirus represents a C-strain based marker vaccine candidate. We have characterised the replication kinetics of Riems26_E2gif and compared it to the parental C-Riems clone. Autonomous replication of chimeric RNA could be observed after electroporation of in vitro transcribed RNAs into porcine PK15 cells. Further passage on PK15 cells revealed infectious chimeric virus with low titers. However, passage of the chimeric virus on ovine SFT-R cells revealed high titers of virus and were more efficient than passages on porcine cells. Data on characterisation of this new E2-substituted C-strain vaccine candidate will be presented and discussed in comparison to other chimeric viruses like CP7_E2alf and CP7_E2gif (Reimann et al., 2004; Rasmussen et al., 2007).    Acknowledgement: This study was supported by Danish Research Council for Technology and Production Sciences (grant 274-07-0198).    References  • Rasmussen TB, Reimann I, Beer M (2010): Novel DIVA vaccine candidates generated by recombination-mediated mutagenesis. 4th EPIZONE Annual Meeting, St Malo, France.  • Rasmussen,T.B., Uttenthal,A., Reimann,I., Nielsen,J., Depner,K., and Beer,M. (2007). Virulence, immunogenicity and vaccine properties of a novel chimeric pestivirus. J Gen Virol 88, 481-486.  • Reimann,I., Depner,K., Trapp,S., and Beer,M. (2004). An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 322, 143-157.       

Characterization of an E2-Substituted Cstrain Vaccine Candidate with Potential Diva Vaccine Properties

http://orbit.dtu.dk/ws/files/5551263/Poster%20IS%203.pdf

Characterization of an E2-Substituted Cstrain Vaccine Candidate with Potential Diva Vaccine Properties

Abstract

Similar works

Full text

Available Versions

Online Research Database In Technology